Related Articles
miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression Corrigendum in /10.3892/or.2023.8507
miR‑505 suppresses prostate cancer progression by targeting NRCAM Corrigendum in /10.3892/or.2020.7696
miR‑1303 promotes the proliferation, migration and invasion of prostate cancer cells through regulating the Wnt/β‑catenin pathway by targeting DKK3
Identification of miR‑195‑3p as an oncogene in RCC
BCL9, a coactivator for Wnt/β‑catenin transcription, is targeted by miR‑30c and is associated with prostate cancer progression